News Daily News FDA’s Proposed Sodium Reduction Plan Could Have a Big Impact, Analysis Suggests Todd Neale April 11, 2018
News Daily News Less Aggressive HbA1c Targets Recommended by American College of Physicians Michael O'Riordan March 06, 2018
News Daily News Diabetes, Multivessel CAD, and LV Dysfunction? Registry Analysis Gives CABG the Edge Over PCI Michael O'Riordan February 20, 2018
News Daily News Low BP Tied to Poor Outcomes in Hospitalized Patients With HFpEF Todd Neale February 20, 2018
News Daily News TAVR Outcomes Worse When the Right Ventricle Is Dysfunctional Todd Neale February 16, 2018
News Daily News Tool Predicts Stroke Risk in Patients With Systolic Dysfunction After MI Todd Neale February 12, 2018
News Daily News AHA Releases Scientific Statement on Breast Cancer and CVD L.A. McKeown February 01, 2018
News Daily News ‘Call to Action’ in India, Where Hypertension and Diabetes Loom Large Michael O'Riordan January 30, 2018
News Daily News Synopsis of New Hypertension Guidelines Renews Concerns and Controversy L.A. McKeown January 22, 2018
News Daily News High Rate of Clinical Events at 6 Months for Ischemic CVD Patients Michael O'Riordan January 19, 2018
News Daily News Bariatric Surgery: Cardiometabolic Benefits Down, but Not Out, at 5 Years Michael O'Riordan January 18, 2018
News Daily News Registry Challenges LVEF Cutoff for AVR, With Implications for Asymptomatic Patients L.A. McKeown January 04, 2018
News Daily News Competitive Triathletes Show Evidence of Myocardial Fibrosis Michael O'Riordan December 25, 2017
News Daily News Some Concerns About New ‘Tour de Force’ Hypertension Guidelines Todd Neale December 04, 2017
News Daily News ‘J-Curve’ in Hypertension May Be Explained by Differences in Patient Characteristics Todd Neale September 26, 2017
News Daily News New Performance and Quality Metrics for STEMI and NSTEMI Care Michael O'Riordan September 21, 2017
News Daily News Lower Blood Pressure May Protect Against Cognitive Decline in Adults in Their 70s Todd Neale August 22, 2017
News Daily News FDA Clearance of Modified Devices Relies Heavily on Weak Studies, Surrogate Endpoints Michael O'Riordan August 16, 2017